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1. Summary 
Cell-based in vitro experiments consist an essential tool in many research fields as they offer 
a far less complex and easier to manipulate system compared to in vivo models. In most cases, 
investigators can either use established continuous cell lines or opt for primary cells directly 
isolated from the tissue of interest. While cell lines are cost-effective and easy to obtain in high 
numbers, continuous growth is facilitated by their cancer background or by genetic 
manipulation, both of which often limit their ability to simulate the physiology of the tissue of 
origin. Primary cells on the other hand require labor-intensive isolation procedures but 
therefore much closer resemble the in vivo situation in terms of sensitivity, transporter 
expression and physiological behavior. To choose the appropriate tool for each experiment a 
detailed knowledge of the abilities and limitations of both systems is essential, whereas it is 
always recommendable to repeat at least some key experiments in a primary cell system. The 
present thesis aims to assess the implementation of bone marrow-derived 
macrophages (BMDMs), a 3D model of rat brain as well as primary proximal tubular 
cells (PTCs) for mechanistic investigations of inflammatory and metabolic diseases in different 
research projects. 
The first project implements BMDMs in the assessment of hexose-6-phosphate 
dehydrogenase (H6PD) function in macrophage differentiation and metabolism. Macrophages 
are phagocytic cells present in essentially all tissues fulfilling various functions vital for tissue 
repair, homeostasis and immunity. During pathological and homeostatic inflammatory 
reactions they arise from the bone marrow under the influence of macrophage-colony 
stimulating factor, patrol the body and eventually enter compromised tissue. Presence of 
lipopolysaccharide and interferon gamma will differentiate them into a pro-inflammatory M1 
phenotype producing toxic effector molecules and inflammatory cytokines whereas 
interleukin-4 induces an anti-inflammatory M2 phenotype involved in resolution of inflammation 
and promotion of tissue remodeling. For the first study, BMDMs were derived from bone 
marrow progenitor cells flushed from the femurs of wild-type (WT) and H6pd knockout (KO) 
mice. The H6PD produces the cofactor NADPH for the activation of glucocorticoids by oxo-
reduction activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in the endoplasmic 
reticulum (ER). In macrophages this could influence the phenotypic and functional 
differentiation and therefore also their metabolism. Absence of H6pd was reported to cause a 
switch in the bidirectional 11β-HSD1 towards an inactivation of glucocorticoids. Comparing 
BMDMs of WT and H6pd KO mice we found no such switch but only a decrease in 11β-HSD1 
oxo-reduction activity by 40-50 %, indicating an alternative source of NADPH. Furthermore, 
H6pd KO did not cause a major disturbance in macrophage phenotypic differentiation although 
it caused a slightly exaggerated M1 phenotype as well as an overall reduced glucose 
consumption. This study showed the suitability of BMDMs to study macrophage differentiation 
and to perform a variety of assays to assess characteristic macrophage parameters like 
phagocytosis, nitric oxide production or metabolism. Most importantly, by using animal derived 
cells, we could use a H6pd KO mouse which circumvents an incomplete gene knockdown by 
siRNA. 
In the second project, BMDMs were implemented to investigate the contribution of secondary 
calciprotein particles (CPPs) to the process of vascular calcification frequently observed in 
chronic kidney disease (CKD) patients. The formation of primary CPPs is a physiological 
process in which serum proteins prevent the precipitation of calcium and phosphate as 
hydroxyapatite by forming spherical complexes instead. In CKD patients, primary transform 
into secondary CPPs, which were shown to activate macrophages. Nuclear factor erythroid 
2-related factor 2 (NRF2), a master regulator of oxidative cell defense, was reported to play an 
important role in CPP-induced inflammation in CKD. Using BMDMs derived from WT and Nrf2 
KO mice we showed the induction of macrophages by secondary CPPs at concentrations 
measured in CKD patients. Mechanistic studies suggested a TLR4-mediated CPP response, 
which could be reduced or exacerbated by induction or knockdown of Nrf2. Whereas the use 
of Nrf2 KO mice facilitated complete absence of the target gene, the relevance of the study 
would benefit from the use of a human model like human PBMCs. 
A primary cell system that includes a specific type of macrophage, the microglia found in brain, 
can be obtained as part of an in vitro 3D brain model derived from rat embryonic brain tissue. 
These 3D cultures contain all cell types of the brain, including neurons, oligodendrocytes, 
astrocytes and microglia cells. The latter two are involved in neuroinflammation, which can be 
caused by heavy metals such as trimethyltin. The project investigates the combination of three 
risk factors of neurodegenerative diseases, namely the metabolic syndrome characterized by 
low brain insulin and high glucocorticoid levels as well as trimethyltin exposure. Therefore, an 
approach consisting of the described 3D rat brain model, the murine microglia cell line BV-2 
as well as a mouse model of diabetes was used to report the absence of an additive effect of 
the risk factors to neurodegeneration but an increased neuroinflammatory response. The 
implementation of models with various levels of complexity allowed to address mechanistic 
questions using the BV-2 cell line but also to draw more in vivo relevant conclusions by using 
a primary 3D model and in vivo mouse experiments. 
In a fourth project, the implementation of primary PTCs in the investigation of metabolic 
acidosis was assessed. Within the functional unit of a kidney, the nephron, the proximal tubule 
is responsible for 65 % of the total sodium reabsorption as well as most solutes, amino acids 
and low molecular weight proteins. In addition, the proximal tubule plays an important role in 
counteracting metabolic acidosis via a process that involves the uptake of glutamine by the 
glutamine transporter SNAT3 which is mainly expressed in the second and third proximal 
tubule segment. To test the involvement of Nrf2 in the upregulation of SNAT3 in response to 
metabolic acidosis, we exposed primary PTCs isolated from mouse kidneys to acidified 
medium. We could observe an upregulation of Snat3 mRNA, which was prevented by siRNA 
knockdown of Nrf2. Studies in Nrf2 KO mice fed with high acid diet confirmed the in vitro 
findings but also revealed a compensatory adaption of other transporters not detected in the 
primary cell model.  
Overall, the four projects revealed many abilities but also some disabilities of the implemented 
primary cell systems. As the availability of human material is very limited, inducible pluripotent 
stem cell technology will grow more and more important as it increases translational relevance 
of in vitro experiments. However, the described primary cell models will probably remain of 
great use, especially in basic research. 
 
  
2. Preface 
The four papers contained in this thesis describe research projects I contributed to in fields 
that are not directly connected to each other. Whereas field-relevant findings are discussed in 
the respective papers, the thesis focusses on critically evaluating the implementation of the 
different primary cell models in these projects. 
 
  
3. Introduction 
3.1 Immortalized vs Primary Cells 
When Ross Granville Harrison in 1907 placed small pieces of spinal cord on clotted tissue fluid 
to examine neuronal outgrowth, he laid the groundwork for modern cell culture [1, 2]. 
Nowadays, the availability of more than 3600 cell lines from over 150 different species on the 
American Type Culture Collection (ATCC) alone indicates the growing importance of cell-
based in vitro experiments ever since [3]. Cell lines most likely owe their frequent use to the 
fact that they are a cost-effective and easy-to-use tool allowing for high throughput experiments 
free from the ethical concerns that animal testing would bring along. Despite offering all these 
advantages, one should be aware that cell lines are genetically manipulated to facilitate 
continuous growth which may influence their native functions, phenotype or ability to response 
to stimuli. Furthermore, constant passaging required to prevent overgrowth as well as the lack 
of tissue architecture could cause a genetic drift leading to changes in proliferation rate, 
metabolic activities and marker expression [4-8]. Another major problem is the cross-
contamination with other cells [3]. In 1970 it was discovered that many cell lines used at that 
time were contaminated with HeLa cells [9], which is still a problem today [10, 11]. Finally, 
according to a study performed in 1994 a contamination with mycoplasma was suspected in 
15-35 % of all cell lines which can alter gene expression and cell behavior [12].  
At the cost of throughput and labor time, the use of primary cells can solve most of the above-
mentioned problems often observed in cell lines such as uncertain identity or genetic drift, as 
they are isolated directly from the original tissue. Many isolation protocols include a dissection 
of the target tissue and/or a treatment of the tissue with proteolytic enzymes like collagenase 
or trypsin to digest the extracellular matrix connecting the cells [13, 14]. As these cells are not 
modified to facilitate continuous growth, they can only be used for a few passages at best. In 
exchange, they mimic the original cell type much closer in terms of transporter functionality, 
sensitivity and behavior allowing to draw conclusions that are more relevant for the in vivo 
situation [15-17]. Indifferent of immortalized or primary cells, many publications fail to mention 
essential cell culture parameters like passage number, detailed culture conditions or activities 
of used enzymes like trypsin. Furthermore, FBS which is used as a supplement for the culture 
of immortalized and some primary cells shows great batch to batch differences in its 
composition, owed to its natural origin [18]. Finally yet importantly, the person carrying out the 
experiments introduces an additional source of reproducibility issues as slight differences in 
the isolation procedure or cell handling can influence the experimental outcome. 
It is obvious that there is no universal answer whether to use immortalized or primary cells. 
The statistician George Box once said, “All models are wrong but some are useful” which can 
be condensed into “know your model”. The choice of the suitable model should always depend 
on the question at hand, which requires detailed knowledge about abilities and disabilities of 
all available systems. In terms of cell models this means, which characteristics of the original 
tissue are still preserved and which were lost by immortalization or during continuous culture. 
There is no point in using a cell line to investigate a transporter that is no longer expressed. 
Isolating primary cells to investigate basic cell physiology preserved in every immortalized cell 
line is equally impractical. To unite the best of both worlds, basic experiments should be 
performed in a suitable cell line while at least some key experiments should be repeated in the 
appropriate primary cell model. 
3.2 Bone Marrow-Derived Macrophages 
Macrophages are a type of myeloid cells historically characterized by Ilya Metchnikoff via their 
ability to perform phagocytosis, the uptake of solid particles [19]. Today we distinguish many 
different types of macrophages throughout the body displaying a wide range of functional 
diversity depending on their anatomical location [20]. Examples of those specialized resident 
macrophages are the Kupffer cells in the liver, the osteoclasts in the bone or the microglia in 
the brain [21-23]. Together with dendritic cells and monocytes, macrophages form the 
mononuclear phagocyte system (MPS) vital for tissue repair, homeostasis and immunity [24-
28]. According to the MPS model, in adult mammals, bone marrow progenitor cells give rise to 
circulating blood monocytes, which enter the tissue where they undergo differentiation to 
replenish the tissue-resident macrophages population [24, 25]. This system has been 
challenged recently as adult tissue macrophage populations were attributed long-term 
persistence relying on self-renewal and many embryonic macrophage populations are being 
established before the appearance of circulating monocytes [29-32]. Nevertheless, it was 
shown in transplantation experiments that bone marrow-derived macrophages (BMDMs) can 
reconstitute most tissue-resident macrophages expect Langerhans cells of skin and mucosa 
and microglia cells located in brain and spinal cord [30]. Additionally, bone marrow-derived 
monocytes infiltrating tissue remain an important source of macrophages throughout adulthood 
in pathological and homeostatic inflammatory reactions [33, 34]. 
In the adult hematopoiesis, monocytes arise from the bone marrow and enter the blood 
circulation under the influence of macrophage-colony stimulating factor (M-CSF) which 
regulates their survival, proliferation and differentiation [35-37]. Subsequently, these patrolling 
monocytes can be recruited to sites of inflammation by tissue-resident macrophages and 
sentinel monocytes releasing chemokines like monocyte chemoattractant protein 
1 (MCP-1) [38]. Upon binding of MCP-1 to the C-C chemokine receptor type 2 on the monocyte 
surface, they leave the blood vessel and differentiate into tissue macrophages [39, 40]. These 
newly recruited tissue macrophages also upregulate the major histocompatibility 
complex class II and the co-stimulatory molecules CD80 and CD86 allowing them to present 
antigens and thereby activate local adaptive immune responses [41, 42]. Depending on the 
type of stimuli, macrophages can develop a broad range of different phenotypes, whereas the 
M1/M2 polarization scheme describes the two extreme forms of that spectrum [43]. Thereby 
the M1 phenotype occurs upon combined stimulation with interferon gamma (IFNγ) and the 
recognition of a pathogen associated molecular pattern like bacterial lipopolysaccharide (LPS) 
via toll-like receptors (TLRs) at the macrophage surface [44]. M1 macrophages show a strong 
microbicidal and tumoricidal activity and are characterized by the production of toxic effector 
molecules like reactive oxygen species and nitric oxide as well as inflammatory cytokines such 
as interleukin 1 beta (IL-1β), tumor necrosis factor alpha (TNFα) and interleukin 6 (IL-6) [45]. 
M2 macrophages are involved in parasite containment, resolution of inflammation and 
promotion of tissue remodeling and occur in response to the cytokines interleukin 4 (IL-4) or 
interleukin 13, immune complexes, simultaneous triggering of Fc gamma receptor and TLRs 
or anti-inflammatory molecules such as interleukin 10, transforming growth factor beta or 
glucocorticoids (GCs) [46-51].  
Displaying great functional diversity and plasticity, macrophages are critically involved in 
numerous physiological processes, but therefore also a potent source of many pathologies. 
Prominent examples thereof are their involvement in heart/vasculature maintenance and 
atherosclerosis, bone remodeling and osteoporosis, hematopoiesis and leukemia, metabolism 
and diabetes as well as immunity and arthritis as reviewed in detail elsewhere [28, 52-57]. This 
selection demonstrates the importance of a detailed understanding of macrophages in order 
to treat those and many other disorders. Consequently, a wide range of macrophage cell 
models with different characteristics as the mouse RAW 264.7, J774A1, IC-21 or BV-2 as well 
as the human THP-1 or U937 has been established [58-63]. Despite the advantage of 
practically endless propagation, all of these cell lines are either cancer-derived, transfected 
with an oncogene or virally transformed which bares obvious and well-documented 
disadvantages compared to primary macrophages. RAW 264.7 cells for example showed 
significantly reduced phagosome functions and impaired inflammasome activation compared 
to BMDMs, which is essential to know when planning to investigate phagocytosis and 
inflammation [64, 65]. J774A1 were found to respond delayed and much less extensive to 
infection with Mycobacterium tuberculosis [66]. THP-1 cells on the other hand completely lack 
production of the cytokines IL-6 and IL-10 upon stimulation with Pseudomonas aeruginosa and 
are far less responsive to LPS than their in vivo counterparts, the peripheral blood 
monocytes [67, 68]. As this list goes on it becomes obvious, that confirmation of in vitro results 
by a primary cell model should be considered, at least for key experiments. 
Whereas human primary cells often raise ethical concerns, mouse primary macrophages are 
accessible much more easily. There are multiple ways to isolate murine macrophages from 
different sources: residential or elicited peritoneal macrophages, alveolar macrophages and 
BMDMs [69]. Whereas the number of residential macrophages in the peritoneal cavity is 
insufficient for most experiments, increasing their yield by elicitation with thioglycollate bears 
the risk of changed physiology and a hyperresponsive phenotype [69, 70]. Alveolar 
macrophages, influenced by their normal tissue environment show multiple macrophage 
untypical characteristics like an aerobic metabolism, production of hepatocyte growth factor or 
differences in cell surface antigens [71-73]. BMDMs on the other hand can be isolated in large 
numbers and in a relatively quiescent state, preserving the responsiveness to in vitro activation 
stimuli [74, 75]. For this purpose, the bone marrow which contains macrophage progenitor cells 
is flushed from the shaft of the femurs and incubated with M-CSF for 7 days, usually resulting 
in a 90 % homogenous population of mature macrophages (Fig. 1) [69]. Since the isolation 
procedure gives rise to resting macrophages, they can be further differentiated into functional 
M1 or M2 phenotypes by exposing them to LPS and IFNγ or IL-4 respectively, allowing the 
study of different macrophage phenotypes and their differentiation processes. Therefore, 
BMDMs are a versatile and close to in vitro tool to investigate a broad range of macrophage 
functions and phenotypes in health and disease. 
 
Fig. 1. Isolation and differentiation of bone marrow-derived macrophages. Both femurs 
of a mouse are dissected and the epiphyses are cut. The bone marrow is flushed from the 
bone using a syringe, re-suspended and incubated for seven days in presence of M-CSF, 
whereas additional medium is added at day 3. Mature macrophages are then scraped, seeded 
into the final well format and differentiated into M1 or M2 phenotype. M-CSF (macrophage 
colony-stimulating factor); LPS (Lipopolysaccharide); IFNγ (Interferon gamma); IL-4 
(Interleukin 4). 
7 d M-CSF 
Bone Marrow 
Progenitor Cells 
Mature 
Macrophages 
LPS + IFNγ → M1 
IL-4 → M2  
3.3 3D Cultures of Rat Brain 
Irrespectively of its anatomical complexity and functional importance, on a cellular level the 
brain mainly consists of two broad categories of cells: neurons and glia cells [76]. Whereas the 
function of the neurons is reviewed elsewhere, the glia cells, which largely outnumber the 
neurons, serve as a support for the neural network [77, 78]. Mainly based on their morphology, 
the glia cells are further separated into astrocytes, oligodendrocytes and microglia [78]. Partly 
isolated from the rest of the body through the blood brain barrier, each of them fulfill specific 
functions within the brain [79]. Astrocytes maintain water and ion homeostasis, participate in 
synaptic function and contribute to the maintenance of the blood brain barrier whereas 
oligodendrocytes produce the myelin that insulates the axons of the neurons facilitating rapid 
signal conduction [80-82]. Finally, the microglia are phagocytic and immunocompetent cells, 
able to polarize into a pro-inflammatory M1- or an anti-inflammatory M2 like phenotype 
depending on the stimulus [83-86]. Together with astrocytes, microglia cells contribute to 
neuroinflammation, which is a major contributor to neurodegeneration [87, 88]. Therefore, it is 
important to study these cell types as well as their interplay during homeostasis and under 
pathological conditions. 
To study the brain and its unique cell types a variety of models with various complexity are 
available ranging from immortalized cell lines to primary 3D and organotypic brain slice 
cultures [89-91]. Whereas the latter are suitable to perform complex experiments like 
electrophysiological recordings and stimulations, retrograde tracing of fluorescent dyes or long 
term live imaging they require labor intensive dissection steps [89, 92-94]. When focusing on 
a single cell type like microglia, cell lines such as the well-established mouse BV-2 constitute 
a suitable and easy to use model mimicking primary microglia in terms of LPS and IFNγ 
response as well as astrocyte stimulation [91]. Further, there are established protocols for the 
isolation of primary microglial cells obtained from neonatal rats [95]. Obviously, a culture of 
homogenous cells lacks the possibility to study interactions between different cell types, as 
they would occur in vivo, where amplification of astrocyte response by microglial cytokines 
consists a mechanism of neurotoxicity [96]. 3D rat brain cell cultures on the other hand contain 
all types of brain cells and offer a suitable model to study such processes circumventing the 
ethical concerns of using aborted human fetal brain tissue [97, 98]. These cultures can be 
established by mechanical dissociation of rat embryonic brain tissue and culturing of the 
resulting cell mixture in serum-free, chemically defined medium under continuous agitation 
which results in aggregate formation, subsequent rearrangement and maturation [90, 99]. The 
high yield, robustness and serum-free growth and development of this 3D culture system 
makes it a valuable tool to investigate neurotoxicity [90]. 
3.4 Proximal Tubular Cells 
Enabled by its proximal and distal tubular segments the kidney fulfills a fundamental role in 
maintaining the body salt and fluid balance as well as blood pressure homeostasis [100]. 
Failure to do so could causes major disturbances in the circulation and cellular functions like 
blood pressure, cell volume or cellular pH levels [100, 101]. Whereas the adult human kidney 
is estimated to filter 180 liters of blood per day, only 1 % of the therein-contained electrolytes, 
solutes and fluid is excreted, indicating its remarkable reabsorption capabilities [102]. This task 
is performed by the major structural and functional kidney unit, the nephron, which spans the 
regions of the cortex as well as the medulla [103]. Each nephron consists of a glomerular tuft 
containing a capillary network and the Bowman’s capsule as well as a tubule unit with the 
proximal tubule, loop of Henle, distal tubule, connecting tubule and the collecting duct [103]. 
Functionally, a nephron filters blood, reabsorbs electrolytes and fluid and excretes waste 
products, overly abundant electrolytes and water [104]. Thereby, the proximal tubule is 
responsible for approximately 65 % of the total sodium reabsorption as well as most solutes, 
amino acids and low molecular weight proteins [105]. Further, it is involved in the body’s acid-
base balance and glucose metabolism by reabsorbing bicarbonate and glucose [106-108]. 
Structurally, the proximal tubule is separated into three different segments (S1-S3) whereas 
the S1 marks the first part of the proximal convoluted tubule, the S2 contains its late portion 
and the beginning of the proximal straight tubule and the S3 consists of the remaining part of 
the proximal straight tubule [103]. Characteristic for the S1 segment are wide brush border 
membranes and a high number of microvilli as well as a well-developed vacuolar-lysosomal 
system and endocytic compartments, indicating its high transport activity and endocytic 
function [103]. Therefore, the S1 shows the highest rate of solute, amino acid, sodium and fluid 
transport of all renal tubular segments [105]. Along the segments, this capacity decreases 
together with the width of the brush border membrane and the luminal surface area available 
for transport processes [103]. 
In addition to many homeostatic functions, the kidney is also responsible for excretion and 
detoxification of toxic metabolites and drugs [109]. Especially the cells of the proximal 
convoluted tubule with their high transport activity are exposed to high concentrations of drugs 
and their metabolites and therefore the site most frequently damaged [110]. Therefore, many 
models exist to mimic the proximal convoluted tubule in vitro, ranging from immortalized cell 
lines like the HK-2 to primary cells and a complete reconstruction of single perfusable tubules 
using 3D bio printing [111, 112]. Choosing the most suitable model is a trade-off between ease 
of use and closeness to the in vivo situation. Easiest to use are established cell lines like the 
mentioned HK-2, OK, MDCK or LLC-PK1, which despite their usefulness in certain studies 
show limitations in mimicking important proximal tubular cell features [113-115]. For example, 
HK-2 and LLC-PK1 cells failed to express organic anion transporters which limits their use for 
uptake experiments [116, 117]. LLC-PK1 in addition are unable to perform gluconeogenesis 
and show only a moderate response to medium that simulates metabolic acidosis [117, 118]. 
MDCK cells on the other hand showed low activities of apical membrane enzymes whereas 
OK cells lack alkaline phosphatase activity [119, 120]. At the other end of the spectrum are 
highly sophisticated, three dimensional convoluted renal proximal tubules on a chip created by 
using a bio printed extracellular matrix and population by perfusion with renal proximal tubule 
epithelial cells (RPTECs) [111]. Laying in between, primary cells show a good resemblance to 
the in vivo situation while allowing for reasonable throughput due to optimized isolation 
procedures.  
As the kidney contains various functionally and morphologically different compartments, a 
manual dissection step is inevitable in all isolation protocols for primary proximal tubular 
cells (PTCs). Primary PTCs can be isolated from animal kidneys by subjecting dissected cortex 
pieces to collagenase digestion followed by a sieving step separating the longer proximal 
tubule fragments from other segments or glomeruli (Fig. 2) [121]. Afterwards, primary PTCs 
will then grow out of the seeded fragments during a seven-day incubation. Other methods 
relying on microdissection of individual nephron segments have been reported but produce 
lower amounts of starting material and subject cells to mechanical stress [13]. Although frozen 
aliquots of human RPTECs are commercially available and the above described isolation 
procedure could also be applied to rabbit or rat, the lower costs, the relative closeness to 
human and the variety of genetically altered mice makes them the favorable source [122]. 
Mouse primary PTCs grown on a cell culture plate were reported to show proximal tubule 
specific characteristics like the development of a monolayer of polarized cells expressing 
microvilli on the apical side as well as dome formation, which is indicative of tight junctions and 
an intact transcellular transport process [123]. A study using a similar isolation protocol but 
growing the cells on collagen coated membranes reports functional expression of an endocytic 
apparatus, brush border enzymes and a functional sodium-dependent glucose transport 
allowing to perform trans-well transport assays [121]. Despite the dedifferentiation issue, which 
is always a limitation in primary cells cultured outside the tissue of origin, mouse primary PTCs 
retain many functions of the original tissue and therefore offer a great model to study processes 
in health and disease. 
 Fig. 2. Dissection and growth of primary proximal tubular cells. Both kidneys of a mouse 
are removed, de-capsuled and cortex pieces are isolated. The product of a collagenase II 
digestion is then added onto a sieve tower accumulating proximal tubular fragments on the 
lower sieve. Fragments are then plated and incubated for seven days to allow for outgrowth of 
proximal tubular cells. 
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4. Results and Discussion 
4.1 Implementation of Bone Marrow-Derived Macrophages 
4.1.1 Comparison of Bone Marrow-Derived Macrophage Differentiation and Function 
between Wild-Type and Hexose-6-Phosphate Dehydrogenase Knockout Mice 
The hexose-6-phosphate dehydrogenase (H6PD) is an enzyme located in the lumen of the 
endoplasmic reticulum (ER) [124]. Using glucose-6-phosphate, it locally regenerates the co-
factor nicotinamide adenine dinucleotide phosphate (NADPH), which can only be replenished 
from the ER-luminal NADP+ pool, as the ER-membrane is impermeable for pyridine 
nucleotides [125]. Currently, the H6PD is the only well documented ER-enzyme thought to be 
responsible for keeping a high luminal NADPH/NADP+ ratio. Consequently, the H6PD is 
interesting for two reasons: firstly, by maintaining a high NADPH/NADP+ ratio, the H6PD 
exerts oxoreduction activity upon the bi-directional enzyme 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1) which faces to the ER lumen and uses NADPH as a co-
factor for local glucocorticoid (GC) activation [126-128]. Activated GCs like cortisol in human 
or corticosterone in mice are vital for the regulation of many physiological functions and have 
a great influence on cells of the immune system such as macrophages [129-131]. Secondly, 
by converting glucose-6-phosphate to 6-phosphogluconate, the H6PD is able to catalyze the 
first two steps of the ER pentose phosphate pathway, thereby affecting overall metabolic 
functions which could regulate macrophage phenotypic differentiation [132-134]. Therefore, 
we hypothesized that 11β-HSD1 in macrophages of H6pd KO mice would no longer function 
as an oxoreductase activating GCs and that this would influence the phenotypic and functional 
differentiation. 
Trying to answer these questions, we compared BMDMs isolated from wild-type (WT) and 
H6pd knockout (KO) mice. This approach is well suited to study the function of a specific gene 
and the effects of its loss since it circumvents incomplete in vitro gene knockdown which would 
require a 48 h time window to allow degradation of residual H6PD protein and always bares 
the risk of influencing normal cell behavior. Additionally, deriving macrophages from bone 
marrow instead of gaining them from other sources results in high numbers of relatively 
quiescent macrophages which is a necessity when aiming to study macrophage phenotypic 
differentiation [69]. BMDMs have been implemented in identical or at least similar experiments 
as the ones performed in the following paper. Already shown for example was the use of 
BMDMs to study the activity of 11β-HSD1 by measuring corticosterone formation upon addition 
of 11-dehydrocorticosterone as well as the resulting reduction in the mRNA expression of 
inflammatory markers [135, 136]. As BMDMs resemble the patrolling monocytes they are often 
activated in vitro using different stimuli and used for the investigation of macrophage 
differentiation, including phenotype-specific markers and M1-specific cytokine release [137-
139]. Furthermore, many general macrophage functions like phagocytosis, M1-specific nitric 
oxide release and cholesterol efflux are preserved as shown by frequent use of BMDMs as a 
model to study those processes [135, 140, 141]. Finally, BMDMs have already been 
successfully applied in metabolism experiments using an extracellular flux analyzer, as the 
metabolic switch from oxidative phosphorylation in M0 macrophages to aerobic glycolysis in 
LPS-induced M1 macrophages is well preserved in this model [142]. Overall, the following 
paper implements BMDMs to compare a variety of typical macrophage functions between WT 
and H6pd KO to assess the role of H6PD in macrophage. 
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4.1.3 Discussion 
The M1/M2 classification scheme simplifies a continuous spectrum of intermediate 
phenotypes, which a macrophage can adopt in vivo to facilitate an adequate response to a 
certain insult [143]. In literature, a broad range of LPS and IFNγ concentrations is used to 
induce M1 differentiation. As we opted for distinct phenotypes, the concentrations chosen for 
this study were located at the higher end, causing the subsequent characterization to clearly 
show the expected M1/M2 differences in phenotypic marker expression and NO release. This 
indicates a normal differentiation of BMDMs in vitro despite the fact that applied standard 
culture conditions differ from in vivo situation in terms of oxygen exposure, glucose 
concentrations or the presence of fetal bovine serum. Therefore, they seem to be a valid model 
in our hands to assess macrophage differentiation in WT and H6pd KO. 
A whole body knockdown of a gene can cause adaptive changes in the animal, which could 
interfere with the process desired to study. In case of the H6PD, KO animals showed increased 
adrenal size and adrenocorticotropic hormone-stimulated circulating corticosterone 
concentrations, most likely caused by resistance to feedback inhibition of the hypothalamic-
pituitary-adrenal axis normally induced by corticosterone [144, 145]. A similar phenotype was 
observed in 11β-HSD1 KO animals, which caused hyper responsiveness to LPS injection as 
indicated by elevated pro-inflammatory cytokine levels [146, 147]. This hyper responsiveness 
was induced or prevented in BMDMs of both WT and 11β-HSD1 KO mice simply by in vitro 
differentiation in presence or absence of GCs [147]. In our study, this influence of GCs is 
eliminated by ex vivo differentiation of BMDMs of WT and H6pd KO animals, as both are 
cultured in the same medium. This allows the study of a H6pd KO avoiding the compensatory 
effects present during in vivo studies of a full body KO. Therefore, the observed increases in 
mRNA expression and release of cytokines in KO M1 macrophages are most likely GC 
independent. 
The assessment of the reductase activity of 11β-HSD1 in our BMDM model is essential to test 
the occurrence of the switch from reductase to dehydrogenase activity in absence of H6pd. 
Interestingly, in the H6pd KO a reduction in reductase activity by 40-50 % rather than a switch 
did occur. When using non-human cells, it is always important to beware of any species-
specific differences relevant to the hypothesis. In our case, the expression of 11β-HSD1 is 
induced in human M2 macrophages by IL-4, which does not occur in mouse BMDMs [148]. 
This however should not be relevant to our results, as they are obtained from macrophages of 
the M1 phenotype. Additionally, the approximately 50 % reduction of 11β-HSD1 reductase 
activity in H6pd KO was confirmed in our lab using perfused liver of the same H6pd KO mice, 
indicating that the absence of a switch from reductase to dehydrogenase activity is an overall 
phenotype and not a special feature of macrophages (unpublished data). To draw conclusions 
from this finding it is vital to use a KO animal instead of just knocking down H6PD as otherwise 
the observed GC conversion would be suggested to be enabled by remaining H6PD protein 
activity. Finally, 11β-HSD1 is most likely the source of the remaining corticosterone formation, 
as no more corticosterone was detectable upon treatment with an 11β-HSD1 specific inhibitor. 
All this indicates that there is an alternative source of NADPH within the ER.  
Various enzymes have been suggested to contribute to NADPH regeneration in the lumen of 
the ER, two of them are the malic enzyme and the isocitrate dehydrogenase [149]. Even 
though both were shown to increase NADPH in liver microsomes by a factor of ten, they did 
not influence 11β-HSD1 reductase activity, most likely because they do not interact with the 
11β-HSD1 kinetically in contrast to the H6PD [150]. Another candidate would be the 
6-phosphogluconate dehydrogenase, which occurs in the cytosol but was suggested to be 
shuttled into the ER where it could contribute to the NADPH pool [151]. An approach called 
BioID suited to identify possible sources was recently reported [152]. Briefly, a protein of 
interest is fused to a promiscuous biotin ligase, which will then biotinylated proteins in close 
proximity. Upon cell lysis and protein denaturation the biotinylated proteins can be purified and 
identified by mass spectrometry [152]. By fusing the biotin ligase to 11β-HSD1, interacting 
proteins could be identified, whereas the already established co-localized H6PD could serve 
as a positive control. 
Metabolism is an important contributor to macrophage phenotypic polarization and an essential 
prerequisite for their M1 or M2 specific functions. Whereas M1 macrophages undergo a switch 
towards greatly enhanced aerobic glycolysis, M2 macrophages show an increased fatty acid 
oxidation and mitochondrial oxidative phosphorylation [153-157]. In turn, assessment of 
macrophage metabolism can serve as a measure of their polarization status and inflammatory 
potential to detect the influence of a gene KO on macrophage differentiation [142]. Using 
BMDMs from WT and H6pd KO animals an extracellular flux analyzer is an ideal approach to 
further investigate the differences in M1 phenotypic differentiation observed on mRNA and 
protein levels. In addition to the already performed glycolysis stress test, recently developed 
assay kits for the extracellular flux analyzer focus purely on assessing the glycolytic rate, 
allowing for a more precise measurement and optimized detection of metabolic switching. 
Results gained by gene expression studies of both macrophage phenotypes led us to target 
the M1 phenotype for further metabolic investigations. However, additional hints about H6PD 
function could be gathered by comparing mitochondrial oxidation in macrophages of the M2 
phenotype using the same platform. 
In conclusion, BMDMs isolated and differentiated under the described conditions are a suitable 
tool to assess the role of H6PD in GC activation and metabolism in macrophages by comparing 
cells from WT and H6pd KO mice. Due to the controlled conditions of an in vitro culture, 
activation of GC as well as GC independent effects can be studied. Further investigations of 
an alternative source of NADPH in the ER could involve BioID whereas more insight into the 
contribution of H6PD to cell metabolism could be gained by extending the metabolic flux 
analyzer experiments. 
4.1.4 Application of Bone Marrow-Derived Macrophages in Mechanistic Investigations 
of Calcification and Inflammation 
Vascular calcification (VC) is associated with an increased incidence of cardiovascular disease 
in patients suffering from chronic kidney disease (CKD) [158, 159]. It was shown to be a 
predictive marker of subsequent cardiovascular morbidity and mortality and even if the 
mechanism of its pathogenesis is not fully understood, a contribution of lost mineral 
homeostasis, oxidative stress and activation of an innate immune response was 
described [158, 160-163]. Additionally, a role of calciprotein particles (CPPs) has been 
described, which are formed in circulation in presence of serum proteins preventing the 
formation of hydroxyapatite precipitates from calcium and phosphate [164, 165]. These initially 
small spherical complexes called primary CPPs can transform into larger spindle-shaped 
structures, the secondary CPPs [164-167]. A role of CPPs in VC is supported by studies 
detecting secondary CPPs in CKD patients whereas they were absent in healthy control 
subjects [168]. Furthermore, circulating CPP concentration in these patients was associated 
with VC [169, 170]. Increased circulating markers of innate immunity associated with CPP 
concentrations as well as co-localization of macrophages with calcium deposits in plaques led 
to the hypothesis, that the chronic inflammation observed in CKD patients is mediated via 
macrophage activation [171-173]. Furthermore, studies showed that activation of the 
macrophage cell line RAW264.7 by secondary CPPs caused secretion of pro-inflammatory 
cytokines [174]. In this process, the transcription factor nuclear factor erythroid 2-related 
factor 2 (NRF2), a master regulator of antioxidant response, was shown to suppress 
macrophage cytokine release in a mouse model of atherosclerosis, whereas a suppression of 
oxidative stress in macrophages caused a decrease in severity [175-179]. Since the Nrf2 
system was found to be compromised in peripheral blood mononuclear cells (PBMCs) isolated 
from CKD patients, their activation by secondary CPPs could be an important mechanism of 
chronic inflammation in CKD [180]. 
As macrophages are the key element in the mechanism under investigation and a mouse 
model of Nrf2 KO is available, BMDMs were used to investigate the role of CPPs and NRF2 in 
macrophages in the pathology of VC. Additionally, they can be isolated in a rather quiescent 
state, which is vital when studying activation and cytokine release elicited by particles. Since 
in vitro systems of primary cells allow for efficient activation or inhibition of specific targets, the 
process under investigation can be manipulated using the Nrf2 inducer bardoxolone 
methyl (CDDO-Me) to reproduce and modulate the in vivo situation and to perform mechanistic 
studies. The following paper illustrates the implementation of BMDMs in mechanistic 
investigations of VC and inflammation as well as the role of NRF2 therein. 
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4.1.6 Discussion 
The study aims to elucidate the induction of macrophages by CPPs, which could play a role in 
VC, a common contributor to cardiovascular disease in CKD patients [158, 160]. Since the 
release of pro-inflammatory cytokines, which consists a hallmark of macrophage activation is 
conserved in the mouse macrophage cell line RAW264.7, they offer a suitable tool to 
investigate the potential of CPPs to elicit an immune response [174, 181]. However, since the 
study intents to show macrophage stimulation by CPP concentrations found in CKD patients, 
the more sensitive BMDMs are a better model to draw conclusions about the in vivo situation. 
Primary macrophages are not only suitable to study TLR4 mediated response to CPPs, but 
also to other colloidal particles like hydroxyapatite or graphene oxide, which have been 
reported to activate the same receptor [182, 183]. Like in the case of CPPs, BMDMs show a 
higher sensitivity to graphene oxide compared to cell lines like the RAW264.7 [183]. 
Furthermore, as they are derived directly from the animal, primary macrophages from Nrf2 KO 
and WT animals allow studying the role of the gene without siRNA knockdown, which is 
incomplete and possibly interferes with the measured release of pro-inflammatory cytokines. 
A major limitation is of course the use of mouse cells while aiming to produce evidence for a 
mechanism of CPPs in human. To increase translational relevance, mechanistic studies 
should be performed in a human model like human PBMCs. They can be isolated from donor 
blood using a density gradient and a selection by CD14+ labeled magnetic beads and 
subsequent differentiation of the selected fraction by human M-CSF. Using this method, 
reasonable numbers of relatively pure and quiescent macrophages can be obtained, but 
compared to a defined mice strain the cells from human blood will most likely show greater 
donor-donor variability. Mechanistic studies done in RAW264.7 cells could then be repeated 
using the same TLR4 inhibitors or NRF2 inducers already applied in mouse, as they are not 
species specific. Additionally, to further corroborate the involvement of the suggested 
JNK/AP-1 pathway, the phosphorylation of cJun, which is an essential step therein, could be 
inhibited and should prevent elicitation of a macrophage response. 
Overall, the use of both the RAW264.7 cell line as well as BMDMs is justified in this project. 
Whereas the cell line is suitable for mechanistic studies, the more sensitive primary cells are 
to be preferred to investigate effects of human relevant CPP concentrations. Finally, PBMCs 
isolated from human blood would corroborate the findings and further increase the relevance 
for the human situation.  
 
4.2 Implementation of 3D Rat Brain Culture 
4.2.1 Use of 3D Rat Brain Culture to Investigate Mechanisms of Neurodegeneration 
The metabolic syndrome characterized by peripheral hyperglycemia and hyperinsulinaemia is 
a risk factor for neurodegenerative diseases [184]. Type II diabetes, often observed in 
metabolic syndrome, leads to a decreased insulin transport into the brain, which was shown 
to cause cognitive impairment [185-187]. Additionally, patients with metabolic syndrome often 
present elevated circulating cortisol levels suggested to impair hippocampus-dependent 
memory formation [188, 189]. Another risk factor for neurodegenerative disease are 
environmental pollutants like the organotin compound trimethyltin (TMT) used as plastic 
stabilizers and biocides shown to accumulate in the food chain and to cause neurotoxicity [190-
195]. All of these three risk factors, low brain insulin, high GC and TMT exposure, contribute 
to neuroinflammation, which involves microglia cells and astrocytes [87, 88, 186, 188, 195]. 
Similar to other macrophages, microglia cells can assume an alternative phenotype favoring 
tissue repair, or a classical phenotype promoting neurodegeneration [85, 86]. Overall, 
microglia play a central role in neuroinflammation, which in turn is considered a major 
contributing mechanism to neurodegeneration [196, 197]. GCs play a key role in the regulation 
of microglial inflammation by binding to the mineralocorticoid receptor (MR) and the GC 
receptor (GR) [198-201]. In this process, the balance of GC is important, as high 
concentrations activate the GR and suppress the inflammatory response, whereas low doses 
of endogenous GC activate the MR thereby stimulating inflammation [126, 202, 203]. This 
balance between GR and MR activity can be influenced by the action of 11β-HSD1, which 
locally activates GC [202].  
We aimed to investigate the risk of the above-described factors and their combination to cause 
neurodegeneration. Neuroinflammation is a key contributing element therein and not 
exclusively mediated by microglia but also through their interplay with other cell types in the 
brain. Therefore, we not only used BV-2 microglial cells in an isolated setting, but also 3D rat 
brain cultures containing all cell types present in the brain along with in vivo experiments. The 
in vitro systems allow for tight control of contributing factors like GC or insulin content as well 
as TMT exposure and also to assess the contribution of microglia to neurodegeneration. The 
BV-2 cell line mimics microglia and is able to activate astrocytes via cytokine release, as it 
would occur in vivo [91, 204]. 3D cultures established from rat brain form aggregates creating 
a tissue-specific environment that allows for physiological interactions between the different 
cell types as well as exchange of soluble messengers, ideal to simulate the interaction between 
microglia and astrocytes leading to neuroinflammation [90]. The following paper is an example 
of the implementation of primary cell cultures and cell lines to assess complex processes like 
neurodegeneration. 
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4.2.3 Discussion 
This study is a good example for the combined implementation of primary cells, cell lines and 
an in vivo animal model to investigate highly complex and multifactorial pathologies like 
neurodegenerative diseases. By knowing the strengths and limitations of each model, they can 
be applied at the appropriate stage of the study course. At the beginning, 3D rat brain cultures 
were used to examine the contribution of low brain insulin and high GC to TMT-induced 
neurotoxicity and neuroinflammation. This 3D in vitro system offers the complexity of 
containing all cells types found in vivo in a tissue-specific environment while still allowing for 
easy manipulation of single or multiple external factors to simulate different combinations of 
known contributors to neurodegeneration. The resulting correlation between microglial 
reactivity and TMT treatment, which was enhanced by conditions simulating metabolic 
syndrome, was further investigated in murine BV-2 cells. Cell lines are often used in 
mechanistic studies as they are available in high numbers and greatly reduce animal to animal 
variations which would occur in primary cells or during in vivo experiments. Additionally, BV-2 
cells are a suitable model to study activation of microglia by TMT as they were already shown 
to closely mimic primary microglia in this aspect [91, 205, 206]. In turn, the interaction with 
other cells like neurons or astrocytes is lost when using pure microglia cultures which is 
important as astrocytes were reported to dampen microglial activation in response to TMT 
treatment in astrocyte-microglia co-cultures [207]. Upon mechanistic investigation of microglial 
activation by TMT and the modulatory effects of insulin and the MR therein, a mouse model of 
diabetes was used to investigate the consequences in vivo. This approach helps to establish 
a translational relevance which can barely be achieved by in vitro experiments. Indeed, it 
showed that the activation of BV-2 microglia cells by TMT clearly observed in vitro only 
translates into a minor contribution of neurotoxicity to neurodegeneration in vivo. As in vitro 
experiments lack many factors like other contributing cell types or adaptive response 
mechanisms that in vivo could amplify or compensate effects, they should be tested in an in 
vivo model whenever possible. 
Especially when investigating neurodegenerative diseases where GC play a role, the 
difference in the primary GC between rodent and human should be considered. Whereas 
corticosterone is predominant in rodents, in human periphery it is found to circulate at 10-20 
fold lower concentrations than cortisol [208-210]. Also, there is a difference between the 
cerebrospinal fluid and the peripheral GC levels as endothelial cells of the blood brain barrier 
highly express a p-glycoprotein membrane pump, which reduces the access of cortisol but not 
corticosterone to the brain in both rodent and human [211-213]. This leads to a corticosterone 
concentration of 40 % of all GC in human brain suggesting a role therein, supported by the fact 
that corticosterone has a higher affinity for human MR than cortisol and the microglial activation 
in mouse was suggested to be MR mediated [201, 211, 214-216]. 
To further improve the relevance to human, many 3D models using human stem cells are 
developed using human pluripotent stem cells (PSCs) or induced pluripotent stem 
cells (iPSCs) [217]. Unfortunately, when investigating inflammatory components of 
neurodegenerative diseases, 3D systems established from PSCs used to be of questionable 
relevance, as they do not contain microglia cells, since those are of embryonic origin [217-
219]. However, recently the efficient generation of microglia from human PSCs has been 
reported and a 3D neural construct including microglia and a vascular network was 
established, showing ongoing efforts in improving human 3D brain models [220-222]. As 
human PSCs raise ethical questions, many newly developed models make use of iPSCs, 
which can be generated from adult cells and even allow a differentiation into microglia like 
cells [223, 224]. Currently, 3D brain models derived from such cells are being developed 
offering a valuable tool to investigate complex brain disorders [217, 225]. 
Overall, the study shows the combined implementation of the microglia cell line BV-2 and more 
complex 3D rat brain cultures as well as mouse models of diabetes to investigate the 
combination of multiple factors mediating neurotoxicity. As the final aim is to describe a process 
in human brain, 3D models of human iPSCs should be taken into account for future studies. 
 
4.3 Implementation of Primary Proximal Tubular Cells 
4.3.1 Application of Primary Proximal Tubular Cells to Investigate the Role of the 
Oxidative Stress Response Pathway in Metabolic Acidosis 
Through excretion and reabsorption of amino acids as well as synthesis of bicarbonate (HCO3-
), the kidney plays an important role in maintaining body pH homeostasis [101]. The de novo 
synthesis of HCO3- mainly occurs in the proximal tubule by ammoniagenesis, a multistep 
process using glutamine to produce ammonium and HCO3- [226]. The excreted ammonia acts 
as a urinary buffer in the filtrate allowing for additional proton excretion whereas the HCO3- 
replaces the fraction already consumed by acids [101, 227]. During metabolic acidosis the 
extraction rate of glutamine from the plasma is increased, which is most likely mediated to a 
great extent by basolateral glutamine influx transporters of the proximal tubular cells [226]. 
SNAT3 is one of those transporters and was found to be upregulated under chronic metabolic 
acidosis whereas in a Snat3 KO mouse the excretion of urinary NH4+ was reduced [228-231]. 
Recently, Snat3 was found to be the most significantly down-regulated transcript in a 
microarray study comparing WT and Nrf2 KO mice [232]. Nrf2 regulates basal and inducible 
expression of various genes involved in cell defense facilitating a response mechanism against 
chemical and oxidative stress [233, 234]. This raised the question whether in absence of NRF2 
the glutamine efflux transporter SNAT3 can still be induced in kidney in response to metabolic 
acidosis. 
Although a Nrf2 KO mice is available in which metabolic acidosis can be induced by dietary 
acid loading, prior to performing in vivo experiments, first insights can be gained using a much 
more controlled in vitro setup. As the process under investigation occurs in the proximal tubule 
in vivo, primary PTCs are the model of choice. They allow for siRNA knockdown and can be 
cultured in acidified medium simulating metabolic acidosis. Additionally, based on own 
observations, mRNA of Snat3, Nrf2 as well as the NRF2 target gene NAD(P)H-dependent 
quinone oxidoreductase 1 (Nqo1) is detectable in mouse primary PTCs, even though 
expression of Snat3 is rather low. Also, the SNAT3 transporter is primarily expressed in the S3 
segment of the proximal tubule but can be induced in the S2 segment in response to metabolic 
acidosis [230, 235, 236]. Therefore, contaminations by cells of other segments possibly 
introduced by incomplete dissection or faulty separation of the fragments by sieving are 
negligible since they will most likely not contribute to the process under investigation. Overall, 
the study tests the usefulness of primary PTCs as a model for NRF2 mediated oxidative 
response and SNAT3 induction in response to metabolic acidosis. 
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4.3.3 Discussion 
The implementation of mouse primary PTCs revealed many abilities of the system, but also 
some clear limitations as a model to study oxidative stress response in metabolic acidosis. 
PTCs were well suited for siRNA depletion of Nrf2 and tolerated subsequent treatment with 
acidified medium. Furthermore, Snat3 mRNA expression was induced in response to 
decreased pH in scrambled siRNA control cells whereas this did no longer occur in Nrf2 
knockdown cells, indicating an Nrf2-dependent regulation of Snat3. Finally, the knockdown of 
Nrf2 caused a significant downregulation of various NRF2 target genes like Nqo1, glutathione 
S-transferase M1 (Gstm1) or glutamate-cystein ligase catalytic subunit (Gclc) which is in 
agreement with observations in Nrf2 KO animals. Overall, the model is suited to show the 
regulation of Snat3 transcription by Nrf2 in response to medium simulating metabolic acidosis. 
However, the study also exposed clear limitations of the primary cell system, limiting its 
implementation in further mechanistic studies of SNAT3 regulation. The most detrimental 
limitation is the lack of SNAT3 protein detection under any conditions. This is not surprising, 
as despite being induced in response to acidified medium the Snat3 mRNA was detected at 
rather low levels as revealed by RT-PCR gene expression analysis. The reason for this could 
simply be de-differentiation, as it often occurs in primary cells since they are taken from their 
original tissue surrounding providing complex tissue architecture and cultured on 2D culture 
plates. Another explanation could be the isolation method, which theoretically yields a mixture 
of fragments of all S1, S2 and S3 segments of the proximal tubule as well as some “impurities” 
from other segments. While under physiological conditions the SNAT3 transporter was only 
found to be expressed in the S3 segment its expression is induced in the S2 segment during 
metabolic acidosis [230, 235, 236]. This raises the possibility, that the applied method of 
isolation predominantly yields fragments of the S1 segment or that the culture conditions 
somehow favor the outgrowth of this specific segment. This could be tested by staining the 
cultures with segment specific markers such as the S3-specific glucose transporter 5 or the 
solute carrier family 36 member 1 characteristic for the S1 segment [237, 238]. Alternatively, 
there are established isolation and separation protocols that allow for segment specific 
preparations using a Percoll density gradient followed by an antibody-based selection [239]. 
Finally, in vivo studies using an Nrf2 KO mouse model revealed no impairment in the adaption 
of acid-excretion during metabolic acidosis, most likely due to compensatory changes of other 
transporters of the kidney or metabolic redirection of glutamine. Since transport effects cannot 
be detected in a 2D in vitro model of primary PTCs due to the lack of access to the basolateral 
side as it is attached to the culture plate, they do not replace in vivo experiments in this aspect. 
Overall, in vitro experiments with primary PTCs allow for gene knockdown studies and the 
simulation of oxidative stress responses mediated by Nrf2 under metabolic acidosis on the 
mRNA level. As they do not express SNAT3 protein and since transport functions and 
compensatory mechanisms cannot be assessed in the current 2D setting they are not 
applicable for more detailed mechanistic studies of the SNAT3 transporter. 
 
 
  
5. General Conclusion and Outlook 
The four projects contained in this thesis highlight many abilities but also expose some 
disabilities of the in vitro systems applied therein. Investigating the role of H6PD displayed the 
versatile implementations of BMDMs in gene expression analysis, cytokine measurements and 
many macrophage specific functional assays as well as their use in examining phenotypic 
differentiation processes. Additionally, when looking at the activation of macrophages by CPP 
concentrations found in CKD patients, the often-reported increased sensitivity of primary cells 
compared to a respective cell line, in this case the RAW264.7, could be exploited. However, 
in order to draw conclusions for the situation in human, data generated in mouse models like 
the BMDMs should be further corroborated with a human model like the human PBMCs to 
increase translational relevance. Apart from the primary macrophages, the implementation of 
primary PTCs as a model of metabolic acidosis was evaluated. Whilst they were suitable in a 
proof-of-concept experiment displaying Nrf2-dependent upregulation of the glutamine 
transporter SNAT3 in response to acidified medium, they could not be applied for further 
mechanistic investigations due to a lack of SNAT3 protein expression. Overall, certainly the 
strongest argument for the use of primary cells was the possibility of deriving them from WT 
and H6pd KO or Nrf2 KO mice, as this circumvents the use of incomplete gene knockdown 
procedures which could influence normal cell behavior. 
Currently, many efforts are being undertaken into the direction of models more relevant to 
human, but gaining human primary cells or tissue is rather difficult for many reasons. Whereas 
monocytes can be derived from easily accessible PBMCs, gaining other cell types often relies 
on control samples taken during biopsies of a diseased organ or even require a body donation 
which mostly represents the aged population. Cells derived from control biopsies might 
unknowingly be affected by the neighboring diseased sections and therefore not always 
represent the situation in health. This could result in higher donor variability making it 
necessary to use higher numbers of donors to get significant results, further limiting the use of 
such sources. Probably the most promising approach to circumvent those problems are human 
iPSCs gained from mature somatic cells by treatment with specific factors [223]. The iPSC 
technology has the potential to generate improved in vitro models in all areas discussed in this 
thesis such as the investigation of neurodegenerative processes, macrophage research, and 
modelling of kidney pathologies. Brain research could profit from the recent development in 
3D brain models generated from human iPSC of patients, which allows for example to generate 
organoids mimicking Alzheimer’s disease in vitro [217]. Furthermore, in the field of 
macrophage research the iPSC technology enables high throughput generation of disease 
specific macrophages from patient derived human iPSCs, which is a powerful tool to study 
macrophage function and differentiation in health and various disorders [240, 241]. Finally, the 
modelling of kidney diseases and nephrotoxicity screening could vastly be improved by human 
iPSC-derived kidney organoids reported to contain complete nephrons with all relevant 
segments [242]. 
Even though the human iPSC-technology will continue to improve in vitro models in most 
research fields, primary cell models like BMDMs or primary PTCs will probably remain viable 
tools. Especially in basic research or proof-of-concept experiments, they are an appropriate 
method when balancing ease of use and relevance. 
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7. Appendix 
7.1 Supplementary of Chapter 4.1.2 
Table 1: Primer Sequences 
 
  Forward Reverse 
Ppia CAAATGCTGGACCAAACACAAACG GTTCATGCCTTCTTTCACCTTCCC 
Gr TGCTATGCTTTGCTCCTGATCTG TGTCAGTTGATAAAACCGCTGCC 
11β-
hsd1 
TGGTGCTCTTCCTGGCCTACT CCCAGTGACAATCACTTTCTTT 
H6pd CTTGAAGGAGACCATAGATGCG TGATGTTGAGAGGCAGTTCC 
inos ATGAGGTACTCAGCGTGCTCCA CCACAATAGTACAATACTACTT 
Mcp-1 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT 
Il-1β CAACCAACAAGTGATATTCTCCATG GATCCACACTCTCCAGCTGCA 
Tnfα CTTCTGTCTACTGAACTTCGGG TGTCTTTGAGATCCATGCCG 
Il-6 TCCAGTTGCCTTCTTGGGAC AGTCTCCTCTCCGGACTTGT 
Cd206 CTCTGTTCAGCTATTGGACGC TGGCACTCCCAAACATAATTTGA 
Ym1 GATGCAGAACAATGAGATCACC ATGGTAGTGAAAGGAGCAGTTC 
Fizz1 AAGCCTACACTGTGTTTCCTTTT GCTTCCTTGATCCTTTGATCCAC 
 
7.2 Supplementary of Chapter 4.1.5 
 
Supplemental Figure I. Validation of Artificial 1ºCPP and 2ºCPP Size and Architecture 
by Transmission Electron Microscopy  
Artificial 1ºCPP (A) and 2ºCPP (B) were generated as described in the Materials and Methods 
section. The resulting CPP were subsequently imaged using transmission electron 
microscopy. 
 
 Supplemental Figure II. CDDO-Me Increased the Transcription of the Nrf2 Target Gene 
Nqo1 in Primary Murine Bone Marrow-Derived Macrophages  
Primary bone marrow-derived macrophages isolated from C57BL6 mice were exposed to 
CDDO-Me at a concentration of 30 nM or a vehicle control for a period of 12 h. Resulting 
transcription of the Nrf2 target gene Nqo1 was measured by real-time PCR and normalized to 
the house-keeping gene Ppia. Statistical analyses were performed using a Mann-Whitney test, 
and represented as follows: (p ≤ 0.05 = *), (p ≤ 0.01 = **) and (p ≤ 0.005 = ***) 
 
Supplemental Figure III. 2°CPP-Induced Transcription of Mcp1 and Il-1β by Raw 264.7 
Macrophages was Attenuated Upon Pre-Treatment with the TLR4 Suppressing 
Chemical CLI-095  
Raw 264.7 cells were exposed to 2°CPP at a concentration of 100 µg/ml calcium content, 3 
µM Cli-095 or a combination of both. Cli-095 was exposed to macrophages 1 h prior to 2°CPP 
administration. Following 2°CPP administration cells were incubated for 12 h. Following this 
gene transcription of Mcp1 (A) and Il-1β (B) was measured by real-time PCR and normalized 
to the house-keeping gene Ppia. Statistical analyses were performed using a Mann-Whitney 
test, and represented as follows: (p ≤ 0.05 = *), (p ≤ 0.01 = **) and (p ≤ 0.005 = ***) 
 Supplemental Figure IV. 2ºCPP Activate JNK/AP-1 Signaling Through TLR4 and Reduce 
Phosphorylated and Total NFκB p65 Levels Through a TLR4- and Nrf2-Independent 
Mechanism  
RAW 264.7 cells were exposed to 2°CPP at a concentration of 100 µg/ml calcium content, 30 
nM CDDO-Me or a combination of both for 12 h. In the same experiment, RAW 264.7 cells 
were also exposed to 3 µM CLI-095 for 13 h, or pre-exposed to 3 µM CLI-095 for 1 h before 
administration of 2ºCPP at a concentration of 100 µg/ml calcium content and incubation for 
another 12 h. Cell lysates were assessed for protein content of phosphorylated cJUN (A-C), 
cJUN (D-F), phosphorylated NF-κB p65 (G-I), NF-κB p65 (J-L) and the house-keeping protein 
β-ACTIN by Western blot. Densitometry was performed on all Western blots with the resulting 
densitometry data for each blot presented. 
 Supplemental Table I: Oligonucleotide primers used for RT-PCR 
Gene Primer Sequence 
Mouse Ccl2 (Mcp1) Sense GCATTAGCTTCAGATTTACGGGT Antisense GGGCCTCTTCTGCGATTTC 
Mouse Il-1β Sense CAACCAACAAGTGATATTCTCCATG Antisense GATCCACACTCTCCAGCTGCA 
Mouse Tnf-α Sense CTTCTGTCTACTGAACTTCGGG Antisense TGTCTTTGAGATCCATGCCG 
Mouse Nqo1 Sense TTTAGGGTCGTCTTGGCAAC Antisense GTCTTCTCTGAATGGGCCAG 
Mouse Ppia Sense CAAATGCTGGACCAAACACAAACG Antisense GTTCATGCCTTCTTTCACCTTCCC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.3 Supplementary of Chapter 4.2.2 
 
 
 
Supplementary Figure 1 
Effects of insulin and GC on 3D rat brain cell cultures. (A) Dose response of 0 up to 1 
mM insulin in normal versus high GC medium of 3D cell cultures. Effects were assessed 
at DIV31, after 10 day treatment. Effects on cell death were assessed, by total protein content 
and intracellular LDH, and effects on astrocytes, by GS activity measurement. (B) Effect of 
normal insulin versus no insulin in combination with TMT-treatment. Aggregates were 
treated with 0.1, 0.5, and 1 μM of TMT, and effects were assessed on cell death, by total 
protein content and intracellular LDH, on astrocytes, by GS activity measurement, and on 
neurons by activity measurement of ChAT and GAD. 
Statistical significance is indicated with * for effect of the TMT treatment as compared to the 
control (CTR/0), and with # for effects of the medium alone. Two-way ANOVA was performed 
and significance was determined for p-values below 0.05. 
 
 
 
 
 
Supplementary Figure 2 
TMT level in brain of lean versus obese mice. TMT in the anterior brain was indirectly 
estimated by measuring the amount of Sn by inductively coupled plasma mass spectrometry 
(ICP-MS). The Sn concentration (µg/g of brain tissue) was compared between db/+ and db/db 
and showing overall similar brain Sn concentrations for the two genotypes (grey bars). Graphs 
show min-max distribution of a minimum of five individuals per groups, line at mean. 
 
  
 
 
Supplementary Figure 3 
Microglial phenotype markers in 3D rat brain cell model (A) and in brain of lean versus 
obese mice (B). (A) 3D rat brain cell cultures maintained in normal, low insulin, high GC and 
low insulin combined to high GC medium, respectively. Results are expressed as fold change 
of untreated cultures maintained under normal conditions. mRNA expression of M1 markers 
Integrin alpha M (Itgam) and Cluster of differentiation 86 (Cd86), and M2 markers Arginase 1 
(Arg1) and Mannose receptor 1 (Mrc1). Data represent the mean of 9 replicates derived from 
3 independent experiments. The effect of TMT was found to be significant for all four genes, 
whereas insulin alone affected Cd86 expression, and GC alone had a significant effect on 
Mrc1.  
Microglial phenotype markers in BKS db mice. (B) M1 microglial markers Cluster of 
differentiation 16 and 32 (Cd16, Cd32), and M2 markers Arginase 1 (Arg1) and cluster of 
differentiation 206 Cd206 at stages 24 h and 10 days post TMT injection. Graph shows min-
max distribution of expression determined in 4 animals of the vehicle group, and 7 animals of 
the TMT group, horizontal bar at mean. Cd16 and Cd32 expression was tendentially higher in 
saline treated db/db as compared to db/+ (P=0.061 and 0.072 respectively), no such 
tendencies were present in the TMT-treated groups. In the 10 day post-injection group Cd16 
and Cd32 was higher in db/db groups as compared to db/+, showing effect for the genotype 
alone. Arg1 was significantly upregulated in 24 h TMT-treated db/db animals compared to db/+, 
this difference was no longer present after 10 days. 
 
 
 
  
Supplementary Figure 4 
Concentration- and time-dependent effects of TMT in BV-2 microglial cells.  
(A-B) Cells were treated with TMT at concentrations ranging from 0.1 to 2 μM for 24 h. (A) 
Expression of Il-6, 11β-Hsd1 and iNos mRNA upregulated in a TMT concentration-dependent 
manner. (B) TMT concentration-dependent increased release of IL-6 in the culture medium as 
measured by ELISA, and increased 11β-HSD1 activity as assessed by the conversion of 
cortisone to cortisol (% E/F conversion). (C) BV-2 cells were treated either with TMT (1 μM) or 
LPS (10 ng/ml) for 0.25, 0.5, 1, 6, 12, 24 and 48 h. Expression and release of IL-6 was 
measured as above, revealing the peak at 18-24 h of exposure. Results represent mean ± 
SEM of three independent experiments. Significance was determined by one-way ANOVA 
followed by Tukey’s posttest, *p < 0.05. 
 
 
 
7.4 Supplementary of Chapter 4.3.2 
 
 
 
 
 
 
 
 
 
Supplemental Figure S1 Confirmation of Snat3 depletion in Nrf2 KO kidney. WT and Nrf2 KO mice 
were fed a normal diet and Snat3 mRNA expression in the kidney was determined by qPCR analysis. 
Statistical analysis for qPCR was performed with a student's paired t-test ****P≤0.0001.  
 
 
 
 
 
 
 
 Supplemental Figure S2 Characterization of primary proximal convoluted tubular cells (PCT) as a 
model to investigate the biological mechanisms of action of the SNAT3 transporter. Confluent isolated 
PCT were either transfected with 20 nM siRNA targeting Nrf2 or the non-targeting scrambled control, si-
. Following incubation for 24 h, cells were exposed to media adjusted to pH 7.4 or 6.5 for a further 24 h. 
Due to its short half-life, in order to visualize the NRF2 protein, cells were exposed to the proteasome 
inhibitor MG132 at 10 µM for 2 h prior to lysis. QPCR and immunoblotting confirmed the depletion of 
Nrf2 mRNA and protein following Nrf2 siRNA in PCT cells cultured in medium adjusted to a, pH 7.4 and 
b, 6.5. QPCR confirmation of the depletion of the NRF2 target genes Nqo1, Gstm1, Gsta3, Gclc and 
Gclm following Nrf2 siRNA in primary PCT cultured in medium adjusted to c, pH 7.4 and d, 6.5. e, 
SNAT3 protein levels following Nrf2 siRNA in primary PCT cultured in medium adjusted to pH 7.4 and 
6.5. Whole kidney lysates from WT normal diet and WT HCl diet animals were used as a positive control. 
25 µg of sample and control protein were loaded for all immunoblots. The mRNA levels were normalized 
to Ppia. β-ACTIN was used as a house-keeping protein control. Data represent mean ± S.D. of n=4 
independent PCT preparations. Statistical analysis for qPCR was performed with a student's paired t-
test *P≤0.05; **P≤0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S3 The proton handling transporter Nhe4 may help to compensate for the loss 
of Snat3 in Nrf2 KO kidney upon metabolic acidosis. WT and Nrf2 KO mice were fed a normal diet or a 
0.2 M HCl containing diet for 7 days. qPCR analysis of the kidney transporters for; amino acids, a-b, 
B°,+at and y+Lat1, c -d for ammonium Rhgc and Nkcc2, and e-f the sodium/proton exchangers Nhe3 
and Nhe4. mRNA values were normalized to Ppia. Data represent mean ± S.D. of n=6 animals per 
group. Statistical analysis was performed with a one-way analysis of variance (with Tukey's post test); 
*P≤0.05; **P≤0.01; ***P≤0.001. 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S4 Metabolic acidosis caused no changes in the mRNA expression of proteins 
involved in renal calcium handling in Nrf2 KO kidney. WT and Nrf2 KO mice were fed a normal diet or a 
0.2 M HCl containing diet for 7 days. qPCR analysis for a, Ncx1, b, Trpv5, c, Calb1 and d, Pmca4a. 
mRNA values were normalized to Ppia. Data represent mean ± S.D. of n=6 animals per group. 
  
 Supplementary Figure S5 Original full-length images used to create the cropped blots shown in Figure 
1. a, SNAT3 expression under normal diet, b, SNAT3 expression upon 7 days HCl diet. Arrows indicate 
the band quantified by densitometry. Exposure time is shown below each western blotting image. 
  
 Supplementary Figure S6 Original full-length images used to create the cropped blots shown in Figure 
2. a, GLS expression, b, PEPCK expression. Arrows indicate the band quantified by densitometry. 
Exposure time is shown below each western blotting image. 
 Supplementary Figure S7 Original full-length images used to create the cropped blots shown in Figure 
4a-b. a, 4F2HC expression under normal diet, b, and upon 7 days HCl diet. Arrows indicate the band 
quantified by densitometry. Exposure time is shown below each western blotting image. 
 Supplementary Figure S8 Original full-length images used to create the cropped blots shown in Figure 
4c-f. a, LAT2, b, TAT1 expression. Arrows indicate the band quantified by densitometry. Exposure time 
is shown below each western blotting image. 
 Supplementary Figure S9 Original full-length images used to create the cropped blots shown in Figure 
4g-h. B0AT1 expression. Arrows indicate the band quantified by densitometry. Exposure time is shown 
below each western blotting image. 
 
 
 
 
 
  
 Supplemental Figure S10 Full length immunoblots from images presented in supplemental Figure 
S2a and b. Images confirm the depletion of NRF2 protein following Nrf2 siRNA in PCT cells cultured in 
medium adjusted to pH 7.4 and pH 6.5. An amount of 25 µg of sample and control protein were loaded 
for all immunoblots. β-ACTIN was used as a house-keeping protein control. Images were acquired 
with the Imagequant LAS-4000 (Fujifilm) following exposure for 1 min (NRF2) and 10 sec (β-ACTIN). 
  
 Supplemental Figure S11 Full length immunoblots from images presented in supplemental Figure 
S2e. Images show SNAT3 protein levels following Nrf2 siRNA in primary PCT cultured in medium 
adjusted to pH 7.4 and pH 6.5. Whole kidney lysates from WT normal diet and WT HCl diet animals 
were used as a positive control. An amount of 25 µg of sample and control protein were loaded for all 
immunoblots. β-ACTIN was used as a house-keeping protein control. Images were acquired with the 
Imagequant LAS-4000 (Fujifilm) following exposure for 10 min (SNAT3) and 10 sec (β-ACTIN). 
 
  
Supplementary Table 1. Amino acids in plasma in wild-type and Nrf2 KO mice after 
a 7 days HCl load. 
Amino acid (µM) WT Nrf2 KO P-value 
Alanine 424.17 ± 185.51 484.5 ± 97.4 n.s. 
Arginine 48 ± 11.64 59.05 ± 8.27 n.s. 
Asparagine 40.68 ± 13.26 49.32 ± 15.44 n.s. 
Aspartate 7.9 ± 3.51 9.38 ± 1.1 n.s. 
Glutamine 509 ± 36.17 653.67 ± 79.55 0.002 
Glutamate 34.57 ± 4.28 44.05 ± 4.7 0.009 
Glycine 353.33 ± 115.87 669.17 ± 698.89 n.s. 
Histidine 69.83 ± 8.06 88.72 ± 12.04 0.026 
Isoleucine 86.67 ± 21.42 92.18 ± 31.57 n.s. 
Leucine 139.33 ± 16.72 143.33 ± 24.73 n.s. 
Lysine 206.67 ± 43.07 256 ± 39.58 n.s. 
Methionine 58.82 ± 20.41 64.9 ± 10.38 n.s. 
Phenylalanine 73.13 ± 11.18 95.43 ± 17.74 0.026 
Proline 104.78 ± 49.3 123.77 ± 33.62 n.s. 
Serine 166.5 ± 63.7 169.33 ± 34.03 n.s. 
Threonine 258.17 ± 79.58 226.33 ± 68.95 n.s. 
Tryptophan 66.22 ± 14.14 83.1 ± 23.72 n.s. 
Tyrosine 65.77 ± 17.93 78.17 ± 24.4 n.s. 
Valine 215 ± 34.89 234.67 ± 40.12 n.s. 
α-aminoadipic acid 15.25 ± 4.86 13.67 ± 2.81 n.s. 
γ-aminobutyric acid 8.17 ± 1.3 9.85 ± 2.3 n.s. 
Anserine 1.07 ± 1.2 0.88 ± 0.79 n.s. 
β-Alanine 1.24 ± 0.54 1.26 ± 0.28 n.s. 
Citrulline 52.15 ± 11.81 59.55 ± 11.17 n.s. 
Cystine 9.18 ± 4.63 4.46 ± 2.69 n.s. 
GABA 0.2 ± 0.07 0.44 ± 0.17 0.015 
1-M-histidine 4.2 ± 0.86 4.66 ± 0.78 n.s. 
3-M-histidine 3.64 ± 0.88 8.52 ± 0.98 0.002 
OH-Proline 31.63 ± 12.17 27.05 ± 8.98 n.s. 
Ornithine 36.2 ± 13.78 54.23 ± 16.37 n.s. 
Values as mean ± SD, P-value calculated with the Mann-Whitney test 
n.s.: not significant differences 
  
  
Supplementary Table 2. Amino acids in kidney in wild-type and Nrf2 KO mice after a 
7 days HCl load. 
Amino acid  
(µmol/kg kidney) WT Nrf2 KO P-value 
Alanine 1187 ± 233.96 1160.5 ± 243.83 n.s. 
Arginine 44.6 ± 5.68 38.65 ± 6.35 n.s. 
Asparagine 97.9 ± 12.76 116.5 ± 22.66 n.s. 
Aspartate 1902 ± 481.24 1831 ± 364.58 n.s. 
Glutamine 678 ± 149.25 727.5 ± 210.15 n.s. 
Glutamate 3780 ± 431.83 3870 ± 376.62 n.s. 
Glycine 6845 ± 675.21 5205 ± 590.86 0.004 
Histidine 184.75 ± 35.12 116.2 ± 18.48 0.004 
Isoleucine 93.9 ± 21.11 98.35 ± 14.39 n.s. 
Leucine 221.95 ± 19.82 225.65 ± 20.94 n.s. 
Lysine 65.9 ± 11.84 63.05 ± 9.14 n.s. 
Methionine 61.66 ± 37.59 66.45 ± 15.11 n.s. 
Phenylalanine 75.2 ± 8.95 108.7 ± 22.05 0.004 
Proline 102.85 ± 20.03 131.1 ± 30.93 n.s. 
Serine 564 ± 118.08 566 ± 67.93 n.s. 
Threonine 367 ± 85.04 293.75 ± 55.6 n.s. 
Tryptophan 13.13 ± 6.08 20.77 ± 8.29 n.s. 
Tyrosine 93.05 ± 10.72 107.35 ± 37.47 n.s. 
Valine 220.85 ± 21.89 263.9 ± 25.23 0.026 
α-aminoadipic acid 126 ± 16.22 98.55 ± 25.39 n.s. 
γ-aminobutyric acid 16.52 ± 4.68 15.65 ± 3.11 n.s. 
Anserine 12.52 ± 0.98 15.37 ± 1.7 0.041 
β-aminoisobutyric acid 11.05 ± 7.02 23.84 ± 7.93 n.s. 
β-Alanine 2.7 ± 0.31 2.35 ± 0.22 0.009 
Carnosine 2.91 ± 0.38 4.25 ± 1.21 0.015 
Citrulline 19.95 ± 3.87 25.36 ± 4.87 n.s. 
Cystine 325.6 ± 95.42 235.75 ± 55.86 n.s. 
GABA 26.57 ± 8.91 44.85 ± 9.31 n.s. 
1-M-histidine 15.66 ± 3.53 15.55 ± 1.87 n.s. 
3-M-histidine 79.65 ± 25.13 48.32 ± 17.62 0.009 
Homocystine 0.03 ± 0.03 0.02 ± 0.01 n.s. 
OH-Proline 56.05 ± 17.24 41 ± 8.59 n.s. 
Ornithine 15.55 ± 10.64 17.01 ± 9.52 n.s. 
Values as mean ± SD, P-value calculated with the Mann-Whitney test 
n.s.: not significant differences 
 
 
 
 
Supplementary Table 3. Primers used for qPCR analysis of mouse kidney tissue. 
 
Gene Primer Sequence 
mouse Snat1 (Slc38a1) sense TCCTTCAGCCATAAAATCCCTC 
 
anti-
sense 
CCACTCGTGTAGCCAAGATAC 
mouse Snat2 (Slc38a2) sense CCGTCTGCCTTCTACATCAAG  
 
anti-
sense 
CCCAATCCAGCACAATCAAG 
mouse Snat3 (Slc38a3) sense TCGGCTACCTGGGTTACTC 
 
anti-
sense 
GGGAACAGAACAATCGGAACTG 
mouse Snat4 (Slc38a4) sense CCTCGTGCCTACCATCAAATAC 
 
anti-
sense 
AGACCAAAGCCCCAATCTTC 
mouse Snat7 (Slc38a7) sense GTAGTGTACCCGTCTTCAACAG 
 
anti-
sense 
AAGGTTAGGAAGCCACAGATG 
mouse Pepck (Pck1) sense CTGCATAACGGTCTGGACTTC 
 
anti-
sense 
CAGCAACTGCCCGTACTCC 
mouse Gls (glutaminase) sense GTGGTTTCTGCCCAATTACTG 
 
anti-
sense 
CCCAGCAACTCCAGATTTTG 
mouse Tat1 (Slc16a10)  sense CCCCATCGTGAGTGTCTTC 
 
anti-
sense 
TCCATAGGTGAGGTACAGAGG 
mouse 4f2hc (Slc3a2) sense ACCTCACTCCCAACTACCAG 
 
anti-
sense 
ATCAGCTTTCCCACATCCC 
mouse Lat1 (Slc7a5)  sense TCACTACCCTCTCTACCAACC 
 
anti-
sense 
TGAACAGAGACCCATTGACAG 
mouse Lat2 (Slc7a8)  sense AAAGAGATCGGATTGGTCAGC 
 
anti-
sense 
ATCCAGACAATGAGAGCAAGG 
mouse y+lat1 (Slc7a7) sense CTTTATCTACGCTGGAAGGACC 
 
anti-
sense 
GATGAGGGAGTTGATGGTGTC 
mouse Bo,+at (Slc7a9) sense GCTCTTGCAGTCCCAGGCT 
 
anti-
sense 
GGGACTACCCAAGATGCTGGA 
mouse B(o)at1 (Slc6a19) sense CTCATCCTTCTGGTGTTCGAG 
 
anti-
sense 
ATGAAGGACACGAACATGGAG 
mouse Nrf2(Nfe2l2) sense CAGCATGTTACGTGATGAGG 
 
anti-
sense 
GCTCAGAAAAGGCTCCATCC 
mouse Nqo1 sense TTTAGGGTCGTCTTGGCAAC 
 
anti-
sense 
GTCTTCTCTGAATGGGCCAG 
mouse Gclc  sense GGGGTGACGAGGTGGAGTA 
 
anti-
sense 
GTTGGGGTTTGTCCTCTCCC 
mouse Gclm sense AATCAGCCCCGATTTAGTCAG 
 
anti-
sense 
CGATCCTACAATGAACAGTTTTGC 
mouse Car3 sense TGGACGGAGTAAAATACGCTG 
 
anti-
sense 
AATCTGGAACTCGCCTTTCTC 
mouse Nhe3 (Slc9a3) sense CACACCCCGCCCATCTACT 
 
anti-
sense 
CCAGGCATACAGCACTGACATT 
mouse Nhe4 (Slc9a4) sense GAGGATACAGGGAATCAAGCG 
 
anti-
sense 
CTTGCTTCTCACTTGTTTGGG 
mouse Rhcg sense AGTGACCTGGATCCTCTACC 
 
anti-
sense 
GAACTGGCTGAATTGAAACTGG 
mouse Nkcc2 (Slc12a1) sense TGCTAATGGAGATGGGATGC 
 
anti-
sense 
CAGGAGAGGCGAATGAAGAG 
mouse Ncx1 (Slc8a1) sense TCCATCCAGTAGACTTCGTGAT 
 
anti-
sense 
CCAAGCAATTCCTTACAGAGTGA 
mouse Trpv5 sense TGCTGCTATAATGCTGATGGAG 
 
anti-
sense 
GCACGGACTAGGTTCACATTCT 
mouse Calb1 (Calbindin d28k) sense AGAACTTGATCCAGGAGCTTC 
 
anti-
sense 
CTTCTGTGGGTAAGACGTGAG 
mouse Pmca4 (Atp2b4) sense GGATTGGAGAACTTTTGTGGG 
 
anti-
sense 
ATCTCGGCAAGGTCAATCTC 
mouse Cyp2a5 sense GGACAAAGAGTTCCTGTCACTGCTTC 
 
anti-
sense 
GTGTTCCACTTTCTTGGTTATGAAGTCC 
mouse Gsta3 sense GGTTCCTGGTTTGTTCCTTG 
 
anti-
sense 
CTATGGGAAGGACATGAAGGAG 
mouse Gstm1 sense ATACTGGGATACTGGAACGTCC 
 
anti-
sense 
AGTCAGGGTTGTAACAGAGCAT 
mouse Dpys sense TGTGACTATAGCCTGCATGTG 
 
anti-
sense 
CGGGCAAGGGTTTTCATTTC 
mouse Kim1 (Havcr1) sense ACTAAGGGCTTCTATGTTGGC 
 
anti-
sense 
AGCTTCAATCTTAGAGACACGG 
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